Paper Details
- Home
- Paper Details
Cost-effectiveness of pneumococcal vaccination for elderly in Sweden.
Author: LarssonSofie, LeppTiia, NauclerPontus, RothAdam, StorsaeterJann, WolffEllen, ÖrtqvistÅke
Original Abstract of the Article :
INTRODUCTION: The aim was to assess cost-effectiveness of including pneumococcal vaccination for elderly in a national vaccination programme in Sweden, comparing health-effects and costs of pneumococcal related diseases with a vaccination programme versus no vaccination. METHOD: We used a single-co...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.vaccine.2020.05.072
データ提供：米国国立医学図書館（NLM）
Pneumococcal Vaccination: A Cost-Effective Strategy for Protecting Seniors
Pneumococcal disease, a serious bacterial infection, can be a significant health threat, particularly for older adults. This study examines the cost-effectiveness of including pneumococcal vaccination in a national vaccination program for elderly individuals in Sweden. The researchers employed a decision-tree model to assess the health effects and costs associated with pneumococcal vaccination compared to no vaccination.
The Economic Benefits of Vaccination: A Smart Investment for Healthy Aging
The study found that a vaccination program using the 23-valent polysaccharide vaccine (PPV23) could significantly reduce the burden of pneumococcal disease, both for 65-year-olds and 75-year-olds, while also being cost-effective. This is like investing in a reliable camel for a desert journey – it's a smart investment that pays off in the long run. The study suggests that vaccinating individuals aged 75 and older could be considered good value for money.
Protecting Our Seniors: The Importance of Vaccination Programs
The study's findings highlight the importance of public health initiatives that promote vaccination, particularly for vulnerable populations like the elderly. Vaccination programs can significantly reduce the incidence and severity of pneumococcal disease, contributing to healthier aging and reduced healthcare costs. This is like building a robust infrastructure in the desert, providing essential support and protection for those navigating its harsh conditions.
Dr. Camel's Conclusion
This research underscores the importance of vaccination programs as a cost-effective and impactful strategy for protecting seniors from infectious diseases. It's a reminder that even in the harsh realities of healthcare, there are opportunities to make smart investments that lead to healthier and more fulfilling lives. This study is a beacon of hope in the desert of public health, illuminating the path toward better health for all.
Date :
- Date Completed 2021-04-27
- Date Revised 2021-04-27
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.